TAILSTORM HEALTH INC recalls Lidocaine HCL Injection, USP 2% 200mg/10mL (20mg/mL) and EPINEPHRINE HCl 1:200,000, 10 ml Single Dose Vial, Rx only, Co…

Recall date

July 3, 2024

Source

U.S. Food & Drug Administration (FDA) — enforcement report

Recall number

D-0594-2024

FDA classification

Class II

Brand / firm

TAILSTORM HEALTH INC

Sold / distributed

Nationwide in the USA

Why it was recalled

Subpotent Drug: reduced efficacy for epinephrine

Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.

What was recalled

Lidocaine HCL Injection, USP 2% 200mg/10mL (20mg/mL) and EPINEPHRINE HCl 1:200,000, 10 ml Single Dose Vial, Rx only, Compounded drug by Medivant Healthcare, 158 S Kyrene Rd, Chandler, AZ 85226, NDC 81483-0038-0, UPC 3 81483 00380 2